Healthy volunteers help scientists measure how two drugs enter skin and blood

NCT ID NCT07588139

Recruiting now Knowledge-focused Sponsor: Incyte Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early-phase study is enrolling 24 healthy adults aged 18 to 65 to see how two drugs—oral povorcitinib and topical ruxolitinib cream—move into the skin and bloodstream. Participants will take the drugs and have their skin fluid and blood sampled using a special device. The goal is purely to gather information, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

povorcitinib (oral tablet) and ruxolitinib (topical cream)

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Axis Clinicals
RECRUITING

Dilworth, Minnesota, 56529, United States